Your browser doesn't support javascript.
loading
Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa, Jonathan; Tensaouti, Fatima; Lotterie, Jean-Albert; Catalaa, Isabelle; Chaltiel, Leonor; Benouaich-Amiel, Alexandra; Gomez-Roca, Carlos; Noël, Georges; Truc, Gilles; Péran, Patrice; Berry, Isabelle; Sunyach, Marie-Pierre; Charissoux, Marie; Johnson, Corinne; Cohen-Jonathan Moyal, Elizabeth; Laprie, Anne.
Afiliação
  • Khalifa J; INSERM UMR 1214, TONIC (Toulouse NeuroImaging Centre), 31059, Toulouse, France. jonathan.khalifa@hotmail.fr.
  • Tensaouti F; Department of Radiation Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France. jonathan.khalifa@hotmail.fr.
  • Lotterie JA; INSERM UMR 1214, TONIC (Toulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Catalaa I; INSERM UMR 1214, TONIC (Toulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Chaltiel L; Department of Nuclear Medicine, CHU Rangueil, 1 Avenue du Professeur Jean Poulhès, 31400, Toulouse, France.
  • Benouaich-Amiel A; INSERM UMR 1214, TONIC (Toulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Gomez-Roca C; Department of Radiology, CHU Rangueil, 1 Avenue du Professeur Jean Poulhès, 31400, Toulouse, France.
  • Noël G; Department of Biostatistics, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France.
  • Truc G; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France.
  • Péran P; Clinical Research Unit, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot Curie, 31100, Toulouse, France.
  • Berry I; Department of Radiation Oncology, Centre Paul Strauss, EA 3430, University of Strasbourg, 3 rue de la Porte de l'Hôpital, 67065, Strasbourg, France.
  • Sunyach MP; Department of Radiation Oncology, Centre Georges-François Leclerc, 1 rue Professeur Marion, 21079, Dijon, France.
  • Charissoux M; INSERM UMR 1214, TONIC (Toulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Johnson C; Université Toulouse III Paul Sabatier, UMR 1214, 31059, Toulouse, France.
  • Cohen-Jonathan Moyal E; INSERM UMR 1214, TONIC (Toulouse NeuroImaging Centre), 31059, Toulouse, France.
  • Laprie A; Department of Nuclear Medicine, CHU Rangueil, 1 Avenue du Professeur Jean Poulhès, 31400, Toulouse, France.
J Neurooncol ; 130(1): 181-192, 2016 10.
Article em En | MEDLINE | ID: mdl-27502603
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Angiografia por Ressonância Magnética / Imagem de Difusão por Ressonância Magnética / Quimiorradioterapia / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Angiografia por Ressonância Magnética / Imagem de Difusão por Ressonância Magnética / Quimiorradioterapia / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article